Eli Lilly

Confidence is high for Eli Lilly CEO Ricks in showdown with Biogen's Aduhelm
Fierce Biotech
Fri, 01/21/22 - 11:13 am
Eli Lilly
Biogen
Alzheimer's disease
Aduhelm
donanemab
clinical trials
David Ricks
Eli Lilly lines up metabolic pacts with Evotec, Abbisko as it awaits diabetes med nod from FDA
Fierce Biotech
Tue, 01/18/22 - 11:49 pm
Eli Lilly
Evotec
Abbisko Therapeutics
diabetes
Two new drugs added to WHO list of COVID-19 therapies
Pharmaforum
Mon, 01/17/22 - 10:26 am
WHO
COVID-19
Eli Lilly
olumiant
GSK
Vir Biotechnololgy
sotrovimab
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
M&A
biotech
Amylyx Pharmaceuticals
Arena Pharmaceuticals
AstraZeneca
Aurinia Pharmaceuticals
Biogen
Biohaven
Bristol Myers Squibb
Eli Lilly
GSK
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
FDA
adagrasib
donanemab
faricimab
lecanemab
tezepelumab
tirzepatide
vutrisiran
Eli Lilly
Mirati Therapeutics
Roche
Chugai
Eisai
Biogen
AstraZeneca
Amgen
Alnylam
JPM22, Day 3: In short order, Perrigo part of a new landscape; Legend, J&J prep for cilta-cel launch
Fierce Pharma
Wed, 01/12/22 - 11:22 pm
JPMHC 2022
Bausch Health
Amgen
Eli Lilly
Perrigo
JNJ
Legend Biotech
JPM 2022: Eli Lilly CEO mulls using Novo's double-branding trick on tirzepatide—one obesity, one diabetes
Fierce Pharma
Wed, 01/12/22 - 11:10 am
JPMHC 2022
Eli Lilly
Dave Ricks
tirzepatide
diabetes
obesity
Biopharma’s stock market winners of 2021 revealed
EP Vantage
Wed, 01/12/22 - 10:50 am
biotech stocks
Eli Lilly
Pfizer
Abbott Labs
Moderna Therapeutics
Merck KGaA
Novo Nordisk
BioNTech
Biohaven
Prothena
Bicycle Therapeutics
Bellus Health
Evolus
Eli Lilly taps Entos' delivery tech in $50M-plus nucleic acid pact
Fierce Biotech
Thu, 01/6/22 - 11:22 am
Eli Lilly
Entos Pharmaceuticals
proteolipid vehicles
drug delivery
2022 forecast: How marketers must learn from Biogen's marketing struggles with Aduhelm
Fierce Pharma
Mon, 12/27/21 - 11:10 am
Biogen
Aduhelm
pharma marketing
Alzheimer's disease
Roche
Eli Lilly
Lilly's Phase 3 Study Of Lebrikizumab In Atopic Dermatitis Meets All Goals
NASDAQ
Tue, 12/21/21 - 10:30 am
Eli Lilly
lebrikizumab
monoclonal antibodies
atopic dermatitis
clinical trials
Eli Lilly enters strike mode ahead of pivotal Alzheimer's, diabetes launches, CFO says
Fierce Pharma
Mon, 12/20/21 - 11:04 am
Eli Lilly
Alzheimer's disease
diabetes
donanemab
tirzepatide
Eli Lilly joins Verge Genomics’ $98M round as AI-discovered ALS drug nears clinic
MedCity News
Fri, 12/17/21 - 10:48 am
Verge Genomics
Eli Lilly
ALS
artificial intelligence
funding
Lilly ups revenue forecast amid windfall from COVID-19 drugs
BioPharma Dive
Wed, 12/15/21 - 11:46 pm
Eli Lilly
COVID-19
US pauses distribution of GSK/Vir's Covid mAb not due to Omicron, but greater supply of Eli Lilly mAbs
Endpoints
Wed, 12/15/21 - 10:42 am
GSK
Vir Biotechnology
Eli Lilly
monoclonal antibodies
COVID-19
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform
PR Newswire
Mon, 12/13/21 - 10:51 am
Eli Lilly
Foghorn Therapeutics
oncology
Eli Lilly pens $1.5B biobucks pact with China's Regor for metabolic disease work
Fierce Biotech
Fri, 12/10/21 - 11:05 am
Eli Lilly
China
Regor Therapeutics
metabolic disorders
Infants, kids now have a Covid-19 therapy as FDA expands use of Eli Lilly drug
MedCity News
Sun, 12/5/21 - 10:39 pm
Eli Lilly
FDA
COVID-19
pediatric
antibodies
'What it takes': As Lilly's Alzheimer's drug approaches FDA, launch leader feels 'amplified' sense of excitement
Fierce Biotech
Tue, 11/30/21 - 10:25 am
Eli Lilly
donanemab
Alzheimer's disease
Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China's latest cost squeeze
Fierce Pharma
Mon, 11/29/21 - 10:55 pm
Novo Nordisk
Sanofi
Eli Lilly
insulin
China
diabetes
drug pricing

Pages